These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32430057)

  • 1. Adjuvant corticosteroid therapy for critically ill patients with COVID-19.
    Lu X; Chen T; Wang Y; Wang J; Yan F
    Crit Care; 2020 May; 24(1):241. PubMed ID: 32430057
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
    Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
    PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
    Arabi YM; Chrousos GP; Meduri GU
    Intensive Care Med; 2020 Nov; 46(11):2067-2070. PubMed ID: 33026460
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
    Zha L; Li S; Pan L; Tefsen B; Li Y; French N; Chen L; Yang G; Villanueva EV
    Med J Aust; 2020 May; 212(9):416-420. PubMed ID: 32266987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
    Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early tocilizumab treatment could improve survival among COVID-19 patients.
    Campins L; Boixeda R; Perez-Cordon L; Aranega R; Lopera C; Force L
    Clin Exp Rheumatol; 2020; 38(3):578. PubMed ID: 32456769
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
    Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
    Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Stay Cool toward Corticosteroids.
    Fujishima S
    Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
    [No Abstract]   [Full Text] [Related]  

  • 11. Caution against corticosteroid-based COVID-19 treatment.
    Tang C; Wang Y; Lv H; Guan Z; Gu J
    Lancet; 2020 Jun; 395(10239):1759-1760. PubMed ID: 32464115
    [No Abstract]   [Full Text] [Related]  

  • 12. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.
    Herman P; Vincent C; Parietti Winkler C; Loundon N; Couloigner V; Tankere F; Tringali S; Gallet P; Papon JF; Montava M; Lavieille JP; Charpiot A; Schmerber S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2020 Sep; 137(4):315-317. PubMed ID: 32482571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
    Yahya AS; Khawaja S; Chukwuma J
    Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
    [No Abstract]   [Full Text] [Related]  

  • 14. Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas?
    Rosell-Díaz AM; Mateos-Mayo A; Nieto-Benito LM; Balaguer-Franch I; Hernández de la Torre-Ruiz E; Lainez-Nuez A; Suárez-Fernández R; Bergón-Sendín M
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e561-e563. PubMed ID: 32495400
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series.
    Yang SS; Lipes J
    Can J Anaesth; 2020 Oct; 67(10):1462-1464. PubMed ID: 32394335
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaphylactic shock following the diagnosis of coronavirus disease 2019.
    Alvarez-Perea A; Baeza ML
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):477-478. PubMed ID: 32745608
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
    J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study.
    Abou-Arab O; Huette P; Debouvries F; Dupont H; Jounieaux V; Mahjoub Y
    Crit Care; 2020 Nov; 24(1):645. PubMed ID: 33183348
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
    Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
    J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding of COVID-19 based on current evidence.
    Sun P; Lu X; Xu C; Sun W; Pan B
    J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.